Frank Bayuk and Bethany Schneider discuss their approach to potential case weaknesses, and how they won a $7 million verdict in a Yamaha rollover crash trial. Watch the full interview, as well as openings in the trial, here. 

Adeptly addressing potential weaknesses in your case is critical to persuading a jury at trial. And in a wide-ranging interview breaking down how they won a $7 million verdict against Yamaha for the injuries a toddler suffered in a golf car rollover crash, Bayuk & Pratt’s Frank Bayuk and Schneider Injury Law’s Bethany Schneider discussed how they masterfully undercut a major potential weakness in their case.

Mark Lanier's damages road map is part of one of CVN's new playlists on demonstratives in closings. Check out the entire Playlist Library here. 

A creative demonstrative can be a powerful tool to bolster a damages argument and memorably summarize the fallout from an injury at the heart of a case. And in a headline-grabbing talc trial, Mark Lanier took jurors along a damages “road map” that ultimately led to a massive trial verdict. 

Shane Read discusses how Sean Claggett undercut defense arguments to win a massive verdict in a deadly crash case. You can watch the full trial here. 

Powerfully countering your opposing parties’ arguments is a critical portion of any opening statement. And in the latest episode of Trial Technique Spotlight, Shane Read, one of the nation’s preeminent trial consultants, details how Claggett & Sykes' Sean Claggett undercut a defendant waste management company’s contentions about a deadly collision, setting up a blockbuster verdict. 

Stock image.  

Miami, FL— Jurors last week cleared Philip Morris of responsibility for the laryngeal cancer a Florida woman developed after years of smoking the company’s "Virginia Slims" cigarettes. Santana v. Philip Morris. 

Stock image. 

CVN has covered a wide range of trials from coast to coast over the last few months: from a California med mal, birth injury claim to a Florida ovarian cancer, talc case involving Johnson & Johnson. Watch a few key moments from these headline-making trials.